The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Open accessAbstract
Inflammation predisposes to the development of cancer and promotes all stages of tumorigenesis. Cancer cells, as well as surrounding stromal and inflammatory cells, engage in well-orchestrated reciprocal interactions to form an inflammatory tumor microenvironment (TME). Cells within the TME are highly plastic, continuously changing their phenotypic and functional characteristics. Here, we review the origins of inflammation in tumors, and the mechanisms whereby inflammation drives tumor initiation, growth, progression, and metastasis. We discuss how tumor-promoting inflammation closely resembles inflammatory processes typically found during development, immunity, maintenance of tissue homeostasis, or tissue repair and illuminate the distinctions between tissue-protective and pro-tumorigenic inflammation, including spatiotemporal considerations. Defining the cornerstone rules of engagement governing molecular and cellular mechanisms of tumor-promoting inflammation will be essential for further development of anti-cancer therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citationGalluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 2×
“However, inducers of TEI in microbial-rich versus “sterile” tumors may be different (Hanahan and Coussens, 2012; Mantovani et al., 2008).”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,001
Regenerative inflammation: When immune cells help to re‐build tissues
Caballero‐Sánchez, N., Alonso‐Alonso, S., & Nagy, L. (2022) · FEBS Journal · doi:10.1111/febs.16693 · Cited by 100
Ahmad, S., Manzoor, S., Siddiqui, S., Mariappan, N., Zafar, I., Ahmad, A., & Ahmad, A. M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.01.003 · Cited by 89
Crosstalk between Macrophages, T Cells, and Iron Metabolism in Tumor Microenvironment
Shen, L., Zhou, Y., He, H., Chen, W., Lenahan, C., Li, X., Deng, Y., Shao, A., & Huang, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8865791 · Cited by 92
Neutrophil Extracellular Traps (NETs) in Cancer Metastasis
Kaltenmeier, C., Simmons, R. L., Tohme, S. T., & Yazdani, H. O. (2021) · Cancers · doi:10.3390/cancers13236131 · Cited by 93
Targeting interleukin-1β and inflammation in lung cancer
Zhang, J., & Veeramachaneni, N. K. (2022) · Biomarker Research · doi:10.1186/s40364-021-00341-5 · Cited by 99
Liu, W., You, W., Lan, Z., Ren, Y., Gao, S., Li, S., Chen, W., Huang, C., Zeng, Y., Xiao, N., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101448 · Cited by 97
Yang, Y., Gharaibeh, R. Z., Newsome, R. C., & Jobin, C. (2020) · Nature Cancer · doi:10.1038/s43018-020-0078-7 · Cited by 94
Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications
Jacquemin, V., Antoine, M., Dom, G., Detours, V., Maenhaut, C., & Dumont, J. E. (2022) · Cancers · doi:10.3390/cancers14020280 · Cited by 92
Toll‐like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis
Mokhtari, Y., Pourbagheri‐Sigaroodi, A., Zafari, P., Bagheri, N., Ghaffari, S. H., & Bashash, D. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16214 · Cited by 87
Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review
Ferrari, E., Pezzi, M. E., Cassi, D., Pertinhez, T. A., Spisni, A., & Meleti, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136795 · Cited by 93
Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges
Wu, B., Sodji, Q. H., & Oyelere, A. K. (2022) · Cancers · doi:10.3390/cancers14030552 · Cited by 92
Dendrimers as nanoscale vectors: Unlocking the bars of cancer therapy
Dey, A. D., Bigham, A., Esmaeili, Y., Ashrafizadeh, M., Moghaddam, F. D., Tan, S. C., Yousefiasl, S., Sharma, S., Maleki, A., Rabiee, N., et al. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.06.003 · Cited by 89
Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer
Fan, Z., Luo, G., Gong, Y., He, X., Qian, Y., Deng, S., Huang, Q., Yang, C., Cheng, H., Jin, K., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08301-3 · Cited by 86
Li, M., Xi, N., Wang, Y., & Liu, L. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0494-3 · Cited by 91
Wang, R., Zhou, M., Ma, H., Qiao, Y., & Li, Q. (2021) · ChemMedChem · doi:10.1002/cmdc.202000996 · Cited by 93
Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways
Afshari, A. R., Sanati, M., Mollazadeh, H., Kesharwani, P., Johnston, T. P., & Sahebkar, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.01.008 · Cited by 87
Cytokines: Can Cancer Get the Message?
Morris, R. M., Mortimer, T. O., & O'Neill, K. L. (2022) · Cancers · doi:10.3390/cancers14092178 · Cited by 96
Borowczak, J., Szczerbowski, K., Maniewski, M., Kowalewski, A., Janiczek-Polewska, M., Szylberg, A., Marszałek, A., & Szylberg, Ł. (2022) · Biomedicines · doi:10.3390/biomedicines10071670 · Cited by 93
CircPVT1 promotes ER‐positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS
Jia, Y., Wang, L., Hu, G.-S., Zhang, Y., Du, J., Ding, J., Ji, X., Shen, H., Huang, H., Ye, F., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022112408 · Cited by 92
Kubatka, P., Mazuráková, A., Samec, M., Koklesová, L., Zhai, K., AL-Ishaq, R. K., Kajo, K., Biringer, K., Výbohová, D., Brockmueller, A., et al. (2021) · The EPMA Journal · doi:10.1007/s13167-021-00257-y · Cited by 86
Living Leukocyte‐Based Drug Delivery Systems
Chen, Y., Qin, D., Zou, J., Li, X., Guo, X. D., Tang, Y., Chuang, L. I. U., Chen, W., Kong, N., Zhang, C. Y., et al. (2022) · Advanced Materials · doi:10.1002/adma.202207787 · Cited by 85
Unveiling the link between chronic inflammation and cancer
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100347 · Cited by 103
The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis
Zielińska, K. A., & Katanaev, V. L. (2020) · Cancers · doi:10.3390/cancers12103071 · Cited by 85
Risk of Stroke in Cancer Survivors
Zhang, F., Wang, K., Du, P., Yang, W., He, Y., Li, T. X., & Mei, Z. (2020) · Neurology · doi:10.1212/wnl.0000000000011264 · Cited by 84
Tewari, D., Bawari, S., Sharma, S., DeLiberto, L. K., & Bishayee, A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107876 · Cited by 81
Divergent functions of NLRP3 inflammasomes in cancer: a review
Shadab, A., Mahjoor, M., Abbasi‐Kolli, M., Afkhami, H., Moeinian, P., & Safdarian, A.-R. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01235-9 · Cited by 87
Yang, Q., Ouyang, J., Sun, F., & Yang, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590685 · Cited by 87
Tumor hijacks macrophages and microbiota through extracellular vesicles
Jiang, J., Mei, J., Ma, Y., Jiang, S., Zhang, J., Yi, S., Feng, C., Liu, Y., & Liu, Y. (2022) · Exploration · doi:10.1002/exp.20210144 · Cited by 84
Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer
Fonteneau, G., Redding, A., Hoag-Lee, H., Sim, E. S., Heinrich, S., Gaida, M. M., & Grabocka, E. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1672 · Cited by 86
Aguilar‐Cázares, D., Chavez-Dominguez, R., Marroquin-Muciño, M., Perez-Medina, M., Benito-Lopez, J. J., Camarena, Á., Rumbo‐Nava, U., & López-González, J. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.929572 · Cited by 85
Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective
Chahal, S., Rani, P., KIRAN, K., Sindhu, J., Joshi, G., Ganesan, A., Kalyaanamoorthy, S., Mayank, M., Kumar, P. P., Singh, R., et al. (2023) · ACS Omega · doi:10.1021/acsomega.3c00692 · Cited by 90
Laskar, R. S., Qu, C., Huyghe, J. R., Harrison, T. A., Hayes, R. B., Cao, Y., Campbell, P. T., Steinfelder, R. S., Talukdar, F. R., Brenner, H., et al. (2024) · Annals of Oncology · doi:10.1016/j.annonc.2024.02.008 · Cited by 87
Vo, T. T. T., Vo, Q. C., Tuan, V. P., Wee, Y., Cheng, J. H.-C., & Lee, I. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102124 · Cited by 81
Yin, Y., Tang, W., Ma, X., Tang, L., Zhang, Y., Yang, M., Hu, F., Li, G., & Wang, Y. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.133848 · Cited by 81
Iyer, H. S., Hart, J. E., James, P., Elliott, E. G., DeVille, N. V., Holmes, M. D., Vivo, I. D., Mucci, L. A., Laden, F., & Rebbeck, T. R. (2022) · Environment International · doi:10.1016/j.envint.2022.107164 · Cited by 85
Hu, Z., Zhao, T. V., Huang, T., Ohtsuki, S., Jin, K., Goronzy, I. N., Wu, B., Abdel, M. P., Bettencourt, J. W., Berry, G. J., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00585-x · Cited by 84
Fantastic voyage: The journey of NLRP3 inflammasome activation
Que, X., Zheng, S., Song, Q., Pei, H., & Zhang, P. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.01.009 · Cited by 91
Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy
Zhang, S., Meng, Y., Zhou, L., Qiu, L., Wang, H., Su, D., Zhang, B., Chan, K. M., & Han, J. (2022) · MedComm · doi:10.1002/mco2.173 · Cited by 85
Flavonoids: A Myth or a Reality for Cancer Therapy?
Forni, C., Rossi, M., Borromeo, I., Feriotto, G., Platamone, G., Tabolacci, C., Mischiati, C., & Beninati, S. (2021) · Molecules · doi:10.3390/molecules26123583 · Cited by 79
The duality of human oncoproteins: drivers of cancer and congenital disorders
Castel, P., Rauen, K. A., & McCormick, F. P. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0256-z · Cited by 80
Jiao, Y., Li, J., Qian, C., & Fei, S. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106047 · Cited by 83
Genus Ziziphus for the treatment of chronic inflammatory diseases
Alsayari, A., & Wahab, S. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.07.076 · Cited by 79
Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications
da Costa, V. R., Araldi, R. P., Vigerelli, H., D’Ámelio, F., Mendes, T. B., Gonzaga, V. F., Policiquio, B. D. O., Colozza‐Gama, G. A., Valverde, C. W., & Kerkis, I. (2021) · Cells · doi:10.3390/cells10102617 · Cited by 80
Mesenchymal stem cells: Biological characteristics and application in disease therapy
Lou, S., Duan, Y., Nie, H., Cui, X., Du, J., & Yao, Y. (2021) · Biochimie · doi:10.1016/j.biochi.2021.03.003 · Cited by 81
Hacker, U. T., Hasenclever, D., Baber, R., Linder, N., Busse, H., Obermannova, R. L., Dubská, L. Z., Valík, D., & Lordick, F. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.03.274 · Cited by 76
Epigenetic Regulation of Inflammatory Signaling and Inflammation-Induced Cancer
Tan, S. Y. X., Zhang, J., & Tee, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.931493 · Cited by 86
New Insights Into the Anticancer Effects of p -Coumaric Acid: Focus on Colorectal Cancer
Tehami, W., Nani, A., Khan, N. A., & Hichami, A. (2023) · Dose-Response · doi:10.1177/15593258221150704 · Cited by 82
Castañeda-Reyes, E. D., Perea‐Flores, M. D. J., Dávila-Ortíz, G., Lee, Y., & de Mejı́a, E. G. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s263516 · Cited by 77
Tumour Microenvironment Stress Promotes the Development of Drug Resistance
Seebacher, N. A., Krchniaková, M., Stacy, A. E., Skoda, J., & Jansson, P. J. (2021) · Antioxidants · doi:10.3390/antiox10111801 · Cited by 84
Macrophage diversity in cancer dissemination and metastasis
Mantovani, A., Marchesi, F., Mitri, D. D., & Garlanda, C. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01216-z · Cited by 96
DNA Damage and Activation of cGAS/STING Pathway Induce Tumor Microenvironment Remodeling
Shen, R., Liu, D., Wang, X., Guo, Z., Sun, H., Song, Y., & Wang, D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.828657 · Cited by 77
Tsai, Y., Ko, C.-A., Chen, H., Hsu, C., Lai, C., Lee, Y., Tsai, M., Chang, G., Huang, E. I., & Fang, K. (2022) · Journal of Cancer · doi:10.7150/jca.74930 · Cited by 77
Metabolic determinants of tumour initiation
Brunner, J. S., & Finley, L. W. S. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00773-5 · Cited by 78
Cytokines as key players in obesity low grade inflammation and related complications
Uti, D. E., Atangwho, I. J., Omang, W. A., Alum, E. U., Obeten, U. N., Udeozor, P. A., Agada, S. A., Bawa, I., & Ogbu, C. O. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100585 · Cited by 116
The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
Braumüller, H., Mauerer, B., Andris, J., Berlin, C., Wieder, T., & Kesselring, R. (2022) · Cells · doi:10.3390/cells12010138 · Cited by 81
AmeliMojarad, M., & AmeliMojarad, M. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14856 · Cited by 73
Wang, J., Cao, L., & Xu, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106907 · Cited by 74
Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment
Pagano, E., Elias, J. E., Schneditz, G., Saveljeva, S., Holland, L. M., Borrelli, F., Karlsen, T. H., Kaser, A., & Kaneider, N. C. (2021) · Gut · doi:10.1136/gutjnl-2020-323363 · Cited by 76
Patel, N., Kommineni, N., Surapaneni, S. K., Kalvala, A. K., Yaun, X., Gebeyehu, A., Arthur, P., Duke, L. C., York, S. B., Bagde, A., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120943 · Cited by 73
Huang, Y., Yang, X. F., Meng, Y., Shao, C., Liao, J., Li, F., Li, R., Jing, Y., & Huang, A. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00683-5 · Cited by 76
Toledo, A. P., Reyna‐Jeldes, M., Ortega, L., Coddou, C., & Yévenes, G. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105390 · Cited by 74
Ahmed, A., Mohamed, M. F. A., Allam, R. M., Nafady, A., Mohamed, S. K., Gouda, A. E., & Beshr, E. A. M. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106171 · Cited by 76
The CAM Model—Q&A with Experts
Fischer, D., Fluegen, G., Garcia, P., Ghaffari‐Tabrizi‐Wizsy, N., Gribaldo, L., Huang, R. Y., Rasche, V., Ribatti, D., Rousset, X., Pinto, M. T., et al. (2022) · Cancers · doi:10.3390/cancers15010191 · Cited by 82
AIF1: Function and Connection with Inflammatory Diseases
León-Oliva, D. D., Montero, C. G., Fraile‐Μartinez, O., Boaru, D. L., García-Puente, L., Rios‐Parra, A., Garrido-Gil, M. J., Casanova-Martín, C., García‐Honduvilla, N., Buján, J., et al. (2023) · Biology · doi:10.3390/biology12050694 · Cited by 78
Ultraviolet (UV) radiation: a double-edged sword in cancer development and therapy
Yu, Z.-W., Zheng, M. H., Fan, H., Liang, X., & Tang, Y. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00209-8 · Cited by 79
A generalized theory of age-dependent carcinogenesis
Rozhok, A. I., & DeGregori, J. V. (2019) · eLife · doi:10.7554/elife.39950 · Cited by 74
Targeting macrophages: a novel treatment strategy in solid tumors
Liu, M., Liu, L., Song, Y., Li, W., & Xu, L. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03813-w · Cited by 73
Glucocorticoid regulation of cancer development and progression
Khadka, S., Druffner, S. R., Duncan, B. C., & Busada, J. T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1161768 · Cited by 75
Chronic Inflammation and Blood CancerPreprint
Tzenios, N., Tazanios, M., & Chahine, M. A. (2022) · Preprints.org · doi:10.20944/preprints202211.0365.v1 · Cited by 72
Tumor accomplice: T cell exhaustion induced by chronic inflammation
Fang, L., Liu, K., Liu, C., Wang, X., Ma, W., Xu, W., Wu, J., & Sun, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.979116 · Cited by 72
The Role of the Microbiome in the Etiopathogenesis of Colon Cancer
Tekle, G. E., Andreeva, N., & Garrett, W. S. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042022-025619 · Cited by 78
Han, X., Ma, Y., Chen, Y., Wang, X., & Wang, Z. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05347 · Cited by 70
Role of Anillin in Tumour: From a Prognostic Biomarker to a Novel Target
Nguyen, T. M., & Lee, C. H. (2020) · Cancers · doi:10.3390/cancers12061600 · Cited by 67
Li, L., & Tian, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114504 · Cited by 75
Circular RNA in cancer development and immune regulation
Li, W., Liu, J., Chen, M., Jiang, X., & Zhu, D. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16102 · Cited by 68
Alolga, R. N., Wang, F., Zhang, X., Li, J., Tran, L. P., & Yin, X. (2022) · Antioxidants · doi:10.3390/antiox11071281 · Cited by 88
Wang, X., Liu, C., Chen, J., Chen, L., Ren, X., Hou, M., Cui, X., Jiang, Y., Liu, E., Zong, Y., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00445-8 · Cited by 69
Yang, T., Hao, L., Yang, X., Luo, C., Wang, G., Cai, C. L., Qi, S., & Li, Z. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049123 · Cited by 70
Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs.
Ginckels, P., & Holvoet, P. (2022) · PubMed Central · Cited by 68
Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer
Wu, Q., Tu, H., & Li, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.914730 · Cited by 68
Wang, F., Niu, Y., Chen, K., Yuan, X., Qin, Y., Zheng, F., Cui, Z., Lü, W., Wu, Y., & Xia, D. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0410 · Cited by 69
Mathematical modeling of cancer immunotherapy for personalized clinical translation
Butner, J. D., Dogra, P., Chung, C. D., Pasqualini, R., Arap, W., Lowengrub, J. S., Vittorio Cristini, C., & Wang, Z. (2022) · Nature Computational Science · doi:10.1038/s43588-022-00377-z · Cited by 71
Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases
Chen, Z., Ding, W., Yang, X., Lu, T., & Liu, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117059 · Cited by 71
Wang, S., Pang, L., Liu, Z., & Meng, X. (2021) · BMC Cancer · doi:10.1186/s12885-021-08536-7 · Cited by 65
Heterogeneous Myeloid Cells in Tumors
Dou, A., & Fang, J. (2021) · Cancers · doi:10.3390/cancers13153772 · Cited by 68
Ansari, M. A., Thiruvengadam, M., Venkidasamy, B., Alomary, M. N., Salawi, A., Chung, I.-M., Shariati, M. A., & Rebezov, M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.005 · Cited by 63
Lee, S. Y., Lee, D. Y., Kang, J. H., Kim, J. H., Jeong, J. W., Kim, H. W., Oh, D. H., Yoon, S. H., & Hur, S. J. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111327 · Cited by 69
Role of the mucin-like glycoprotein FCGBP in mucosal immunity and cancer
Liu, Q., Niu, X., Li, Y., Zhang, J.-R., Zhu, S., Yang, Q.-Y., Zhang, W., & Li, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.863317 · Cited by 66
Sofi, S., Jan, N., Qayoom, H., Alkhanani, M., Almilaibary, A., & Mir, M. A. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103774 · Cited by 68
Zhong, H., Jiang, J., Hussain, M., Zhang, H., Ling, C., & Guan, R. (2025) · Advanced Science · doi:10.1002/advs.202500304 · Cited by 75
Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery
Jiang, J., Mei, J., Yi, S., Feng, C., Ma, Y., Liu, Y., Liu, Y., & Chen, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114046 · Cited by 68
Nano-targeting vascular remodeling in cancer: Recent developments and future directions
Giordo, R., Wehbe, Z., Paliogiannis, P., Eid, A. H., Mangoni, A. A., & Pintus, G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.001 · Cited by 67
How does fascin promote cancer metastasis?
Lin, S., Taylor, M. D., Singh, P. K., & Yang, S. (2020) · FEBS Journal · doi:10.1111/febs.15484 · Cited by 65
Leptin, Both Bad and Good Actor in Cancer
Jiménez‐Cortegana, C., López-Saavedra, A., Sánchez-Jiménez, F., Pérez‐Pérez, A., Castiñeiras, J., Virizuela-Echaburu, J. A., de la Cruz‐Merino, L., & Sánchez‐Margalet, V. (2021) · Biomolecules · doi:10.3390/biom11060913 · Cited by 69
Wang, Y., Xu, C., Meng, M., Lin, L., Hu, Y., Hao, K., Shu, S., Zhang, S., Wu, J., Liu, F., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101266 · Cited by 64
Frigerio, S., Lartey, D. A., D’Haens, G., & Grootjans, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312739 · Cited by 66
Liu, L., Cheng, X., Yang, H., Lian, S., Jiang, Y., Liang, J., Chen, X., Mo, S., Shi, Y., Zhao, S., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01516-w · Cited by 68
NF-κB: A Druggable Target in Acute Myeloid Leukemia
Francesco, B. D., Verzella, D., Capece, D., Vecchiotti, D., Nolfi, M. D. V., Flati, I., Cornice, J., Padova, M. D., Angelucci, A., Alesse, E., et al. (2022) · Cancers · doi:10.3390/cancers14143557 · Cited by 64
Pang, J., Ding, N., Liu, X., He, X., Zhou, W., Xie, H., Feng, J., Li, Y., He, Y., Wang, S., et al. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-16454-8 · Cited by 64
Paz-Ares, L. G., Goto, Y., Lim, W., Halmos, B., Cho, B. C., Cobo, M., González-Larriba, J. L., Zhou, C., Demedts, I., Atmaca, A., et al. (2024) · Lung Cancer · doi:10.1016/j.lungcan.2023.107451 · Cited by 63
Metadata
- Authors
- Greten, F. R., & Grivennikov, S. I.
- Affiliations
- Goethe University Frankfurt (DE)
- Fox Chase Cancer Center (US)
- Corresponding author
- Greten, Florian R.
- Grivennikov, Sergei I.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 51
- Issue
- 1
- Pages
- 27-41
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC6831096
- OpenAlex
- W2959497269
- Cited by
- 3,806
- References
- 178
- Citations by year
- 2026: 457 · 2025: 640 · 2024: 753 · 2023: 715 · 2022: 664 · 2021: 397 · 2020: 163 · 2019: 16
- FWCI
- 26.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (R01CA227629, CA218133)
- Pew Scholar in Biomedical Sciences
- US-Israel BSF
- NIH (P30 CA-006927)
- Georg-Speyer-Haus
- LOEWE Center Frankfurt Cancer Institute (III L 5 - 519/03/03.001 - (0015), FOR2438: Gr1916/11-1, SFB 815, 1177, 1292)
- German Federal Ministry of Health
- Ministry of Higher Education, Research and the Arts of the State of Hessen
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- tumor inflammation, tumor inflammatory microenvironment, carcinogenesis, tumor initiation, tumor progression, metastasis, tumor-stroma interactions, cellular plasticity, tissue homeostasis, tissue repair, cancer therapy
- MeSH terms
- Animals, Chronic Disease, Homeostasis, Humans, Infections, Inflammation, Neoplasms, Neovascularization, Pathologic, Wound Healing, Autoimmunity, Tumor Microenvironment, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review